Effect of Rosiglitazone

University Hospital Center (CHU)

Status: Completed

Conditions: Healthy

Treatments: Drug: rosiglitazone

Study type: Interventional

Funder types: Other

Identifiers

NCT00285142

7715

Details and patient eligibility

About

To evaluate :

• acute effects of a single dose of 8 mg rosiglitazone (therapeutic dose)
• on insulin secretion and
• insulin sensitivity in 12 healthy male subjects.

Sex: Male

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• BMI between 18.0 and 24.0

Exclusion criteria

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind